CLINICAL_TRIALS
trial_result
· 2021-11-22
Clinical Trial Update: Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy [Phase 4]
Summary
Phase 4 trial evaluating Xolair as add-on therapy for idiopathic angioedema completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Idiopathic Angioedema | Phase 4 | Status: COMPLETED | Results posted: 2021-11-22